Printer Friendly

THERATECH FILES INITIAL PUBLIC OFFERING OF 2,000,000 COMMON SHARES WITH SEC

 THERATECH FILES INITIAL PUBLIC OFFERING
 OF 2,000,000 COMMON SHARES WITH SEC
 SALT LAKE CITY, March 10 /PRNewswire/ -- TheraTech, Inc. announced today that it filed a registration statement with the Securities and Exchange Commission covering a proposed initial public offering of 2,000,000 common shares. All of the shares are being offered by the company.
 William Blair & Company and Vector Securities International, Inc. will co-manage the underwriting group. The offering is expected in late April at an estimated price of $11.00 to $12.50 a share.
 Net proceeds will be used to fund research and development activities, to construct manufacturing facilities and for working capital and general corporate purposes.
 Headquartered in Salt Lake City, TheraTech, Inc. develops advanced, controlled release drug delivery products which administer drugs through the skin, by oral delivery to the gastrointestinal tract, through tissues in the mouth and by other means. TheraTech, Inc. currently has six drug delivery products in clinical development ranging from Phase I to Phase III, three products in preclinical development and seven products in earlier stages of development.
 -0- 3/10/92
 /CONTACT: Steven C. Mayer, vice president and CFO of TheraTech, 801-583-6028, or Mark A. Timmerman of William Blair & Company, 312-236-1600/ CO: TheraTech, Inc. ST: Utah IN: MTC SU: OFR


SM-AH -- NY070 -- 7084 03/10/92 17:16 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 10, 1992
Words:221
Previous Article:ENSCO STOCKHOLDERS APPROVE PURCHASE
Next Article:CHARMING SHOPPES ANNOUNCES ADDITION TO BOARD OF DIRECTORS
Topics:


Related Articles
CHEMTRAK INCORPORATED FILES INITIAL PUBLIC OFFERING
LIDA FILES A REGISTRATION STATEMENT WITH THE SEC
IMMUNOLOGY LIMITED CHANGES NAME TO CANTAB PHARMACEUTICALS AND ANNOUNCES SEC FILING FOR AN INITIAL PUBLIC OFFERING
THERATECH ANNOUNCES INITIAL PUBLIC OFFERING OF COMMON STOCK
THERATECH, INC. FILES PUBLIC OFFERING OF 1,250,000 COMMON SHARES WITH SEC
1,250,000 THERATECH, INC. COMMON SHARES OFFERED AT $14.00 PER SHARE
ARCTURUS FILES REGISTRATION STATEMENT WITH SEC FOR INITIAL PUBLIC OFFERING OF 2,000,000 SHARES OF COMMON STOCK
AMERICAN HOMESTAR CORPORATION FILES INITIAL PUBLIC OFFERING OF 2,000,000 COMMON SHARES WITH SEC
EAGLE POINT SOFTWARE CORPORATION FILES INITIAL PUBLIC OFFERING OF 2,000,000 COMMON SHARES WITH SEC
INTELLIGENT SYSTEMS CONFIRMS PROPOSED SALE OF STOCK IN OrCAD IPO

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters